ENTOS
LIVE

Serial Number

97978410

Owner

ENTOS PHARMACEUTICALS INC.

Attorney

Theodore R. Remaklus

Filing Date

Sep 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ENTOS Trademark

Serial Number: 97978410 • Registration: 7568415

ENTOS is a trademark filed by ENTOS PHARMACEUTICALS INC. on September 14, 2022. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ENTOS PHARMACEUTICALS INC. (9 trademarks)

10230 JASPER AVENUE, UNIT 4550
EDMONTON, AB T5J4P6 , CA

Entity Type: 03

Trademark Details

Filing Date

September 14, 2022

Registration Date

November 19, 2024

First Use in Commerce

January 23, 2018

Published for Opposition

September 3, 2024

Goods & Services

Custom manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies

Medical therapy services, namely gene therapy services; medical analysis services, namely RNA or DNA analysis for virus diagnosis and prognosis; medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; on-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; genetic testing for medical purpose

Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccines and medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific research purposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products; scientific research, pharmaceutical research, medical research, technical consultation in the field of pharmaceutical studies and product development for others in the field of biotechnology and product development of pharmaceuticals, therapeutic agents and medical devices; research and product development in the field of human vaccines, recombinant proteins and antibodies for therapeutic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 4, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 19, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2024 CNSA
DIVISIONAL PROCESSING COMPLETE
Jun 25, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 12, 2024 AITU
ASSIGNED TO LIE
Apr 6, 2024 ALIE
DIVISIONAL REQUEST RECEIVED
Nov 16, 2023 DRRR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2023 TROA
TEAS REQUEST TO DIVIDE RECEIVED
Nov 16, 2023 ERTD
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 27, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 30, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2022 NWOS
NEW APPLICATION ENTERED
Sep 17, 2022 NWAP